KM

Kevin Malabre

Senior Scientist Upstream at Oxford BioMedica

Kevin Malabre has an extensive background in upstream process development and bioprocessing, with experience in companies such as Oxford Biomedica, UCB, GSK, and Novartis Vaccines. Kevin has worked on improving protein yields for vaccines, conducted fermentations in bioreactors, and implemented scale-down models. Kevin has also managed teams, mentored junior staff, and worked on various analytical tasks using chromatography systems. Their educational background includes a degree in Biotechnology Engineering from Polytech Clermont.

Links

Previous companies

University of Bristol logo
Novartis logo

Timeline

  • Senior Scientist Upstream

    January 1, 2021 - present

  • Scientist Upstream

    June, 2018